HeartFlow Analyst Price Targets

HeartFlow Inc

HTFLNASDAQ

Trade with Public

$50.65

2.364.89%

Dern. MÀJ: Oct 19, 10:57 AM

$48.55

0.260.54%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

HeartFlow Analyst Price Targets

Wall Street analyst price targets and consensus rating for HeartFlow (HTFL).

Price Target Range — 5 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingOverweight# Analysts9Avg. Consensus PT$44Upside to Avg. PT-13.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 22, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$45→$56
Sep 9, 2026	UBS	Doug Schenkel	Initiate	Neutral	$55
Aug 14, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$37→$45
Aug 14, 2026	Morgan Stanley	Patrick Wood	PT Raise	Equal-Weight	$35→$40
Aug 14, 2026	Stifel	Rick Wise	PT Raise	Buy	$40→$45
Aug 14, 2026	Piper Sandler	Matt OBrien	PT Raise	Overweight	$38→$45
Aug 14, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$35→$45
Aug 14, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$37→$39
Jul 31, 2026	Baird	David Rescott	Initiate	Outperform	$34
Jul 1, 2026	Freedom Capital Markets	Gene Mannheimer	Initiate	Buy	$37
May 15, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$43→$37
May 15, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$35→$37
May 4, 2026	William Blair	Brandon Vazquez	Initiate	Outperform	—
Mar 19, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$40→$35
Mar 19, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$40→$43
Mar 19, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$38→$35
Mar 9, 2026	Canaccord Genuity	William Plovanic	Maintained	Buy	$40
Jan 28, 2026	Wells Fargo	Larry Biegelsen	Initiate	Overweight	$38
Nov 13, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$39→$40
Nov 13, 2025	JP Morgan	Robbie Marcus	PT Raise	Overweight	$36→$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $37 to $45.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and raises the price target from $35 to $40.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $38 to $45.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $45.

Benzinga Newsdesk

HeartFlow Inc

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

People Also Watch

People Also Watch

HeartFlow Inc

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PROUBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PROMorgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PROPiper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PROJP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PROUBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PROMorgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PROPiper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PROJP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45